Literature DB >> 23684680

Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve).

Raj R Makkar1, Hasan Jilaihawi, Tarun Chakravarty, Gregory P Fontana, Samir Kapadia, Vasilis Babaliaros, Wen Cheng, Vinod H Thourani, Joseph Bavaria, Lars Svensson, Susheel Kodali, Takahiro Shiota, Robert Siegel, E Murat Tuzcu, Ke Xu, Rebecca T Hahn, Howard C Herrmann, Mark Reisman, Brian Whisenant, Scott Lim, Nirat Beohar, Michael Mack, Paul Teirstein, Charanjit Rihal, Pamela S Douglas, Eugene Blackstone, Augusto Pichard, John G Webb, Martin B Leon.   

Abstract

OBJECTIVES: This study investigated the determinants and outcomes of acute insertion of a second transcatheter prosthetic valve (TV) within the first (TV-in-TV) or transcatheter valve embolization (TVE) after transcatheter aortic valve replacement (TAVR).
BACKGROUND: TAVR failure can occur with both TV-in-TV and TVE as a consequence of TAVR malpositioning. Only case reports and limited series pertaining to these complications have been reported to date.
METHODS: Patients undergoing TAVR in the PARTNER (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve) randomized trial (cohorts A and B) and accompanying registries were studied. Data were dichotomized for those with and without TV-in-TV or TVE, respectively.
RESULTS: From a total of 2,554 consecutive patients, 63 (2.47%) underwent TV-in-TV and 26 (1.01%) TVE. The indication for TV-in-TV was significant aortic regurgitation in most patients, often due not only to malpositioning but also to leaflet dysfunction. Despite similar aortic valve function on follow-up echoes, TV-in-TV was an independent predictor of 1-year cardiovascular mortality (hazard ratio [HR]: 1.86, 95% confidence interval [CI]: 1.03 to 3.38, p = 0.041), with a nonsignificant trend toward greater all-cause mortality (HR: 1.43, 95% CI: 0.88 to 2.33, p = 0.15). Technical and anatomical reasons accounted for most cases of TVE. A multivariable analysis found TVE to be an independent predictor of 1-year mortality (HR: 2.68, 95% CI: 1.34 to 5.36, p = 0.0055) but not cardiovascular mortality (HR: 1.30, 95% CI: 0.48 to 3.52, p = 0.60).
CONCLUSIONS: Acute TV-in-TV and TVE are serious sequelae of TAVR, often resulting in multiple valve implants. They carry an excess of mortality and are caused by anatomic and technical factors, which may be avoidable with judicious procedural planning.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AR; AT; BSA; CABG; CT; LV; TAVI; TAVR; TEE; THV; TIA; TV; TV-in-TV; TVE; V-in-V; aortic regurgitation; as-treated; body surface area; computed tomography; coronary artery bypass; embolization; left ventricular; outcomes; transcatheter aortic valve implantation; transcatheter aortic valve replacement; transcatheter heart valve; transcatheter prosthetic valve; transcatheter prosthetic valve within a transcatheter prosthetic valve; transcatheter valve; transcatheter valve embolization; transcatheter valve-in-surgical valve; transesophageal echocardiograms; transient ischemic attack; valve-in-valve

Mesh:

Year:  2013        PMID: 23684680     DOI: 10.1016/j.jacc.2013.04.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

Review 1.  Guidance of transcatheter aortic valve replacement by echocardiography.

Authors:  Rebecca T Hahn
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

2.  A case of SAPIEN XT valve fallen into left ventricle during valve-in-valve transcatheter aortic valve implantation.

Authors:  Shigeki Koizumi; Natsuhiko Ehara; Kenta Nishiya; Tadaaki Koyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-24

Review 3.  Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance.

Authors:  Rebecca T Hahn; Susheel Kodali; Philippe Généreux; Martin Leon
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

Review 4.  Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature.

Authors:  Krys Milburn; Vinayak Bapat; Martyn Thomas
Journal:  Clin Res Cardiol       Date:  2014-01-21       Impact factor: 5.460

Review 5.  How to Image and Manage Prosthesis-Related Complications After Transcatheter Aortic Valve Replacement.

Authors:  Nina C Wunderlich; Jörg Honold; Martin J Swaans; Robert J Siegel
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

Review 6.  Strategies for Recovering an Embolized Percutaneous Device.

Authors:  Thomas Nestelberger; Mesfer Alfadhel; Cameron McAlister; Rohit Samuel; Jacqueline Saw
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

7.  Balloon- or Self-Expandable TAVI: Clinical Equipoise?

Authors:  John Jose; Gert Richardt; Mohamed Abdel-Wahab
Journal:  Interv Cardiol       Date:  2015-05

Review 8.  Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement.

Authors:  Rebecca T Hahn; Susheel Kodali; E Murat Tuzcu; Martin B Leon; Samir Kapadia; Deepika Gopal; Stamatios Lerakis; Brian R Lindman; Zuyue Wang; John Webb; Vinod H Thourani; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2015-03

9.  Migration and surgical retrieval of transcatheter aortic valve.

Authors:  Ajmer Singh; Vinit Garg; Yatin Mehta
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-09-20

Review 10.  Mechanisms and management of TAVR-related complications.

Authors:  Amir-Ali Fassa; Dominique Himbert; Alec Vahanian
Journal:  Nat Rev Cardiol       Date:  2013-10-08       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.